From the Editors of Pharmaceutical Executive

You are receiving this email as a subscriber to Pharmaceutical Executive

Interested in Learning About Other Topics' Give us your ideas for a Future Webcast or Podcast

*Featured Content:*
Pharm Exec's 2011 Top 50 Pharma Companies Is the recent wave of megamergers enough to counter a looming storm surge of patent expirations? Find out in our annual Pharm Exec 50, which ranks the world's largest pharmaceutical companies by global sales of prescription drugs—a key indicator of market change. See who’s in, who’s out, and who emerged on top……
» Register Free!	Sponsored by: DSM

ON-DEMAND WEBCASTS NOW AVAILABLE FOR REPLAY
ON DEMAND Customer Intimacy - The Pharma Challenge One of the key challenges and areas of focus for the pharmaceutical industry is increasing customer intimacy, be that understanding the perceptions, behaviors, and needs of consumers and patients to support increased adherence or embracing the challenges within the healthcare professionals daily routine to identify opportunities to delivery information and services which provide true “value”. In order to deliver upon either of these objectives, the challenge facing pharma is gaining deep customer insights and intimacy to identify and deliver relevant information and messaging, thereby driving customer engagement, and in turn creating deeper relationships. This process of gaining deeper customer insights starts with analyzing the data available about each customer in new ways.
» Register Free!	Sponsored by: Clinician 1 & PANPharma

ON DEMAND Leveraging the Power of Predictive, Visual Analytics To Maximize Research, Development and Commercial Operations Simplyfying human-data interaction is one of the keys to better decision making across research, development and commercial operations processes. We will explore the capabilities of a sophisticated data visualization and analytics platform that provides reliable navigation through the vast amounts of data generated to run a life science organization providing a clear path to actionable decisions, reliably, rapidly and reproducibly. Learn how the world?s leading pharmaceutical, biotech, medical device, and contract research organizations leverage predictive and visual analytics to discover new therapeutics, develop their pipeline of assets, launch their drugs to the market, and align marketing and sales campaigns to maximize return on their enterprise information investments.
» Register Free!	Sponsored by: Clinician 1 & PANPharma

ON DEMAND Marketing With Power to Nurse Practitioners and Physician Assistants Nurse Practitioners and Physician Assistants. Who are they? Where are they? What makes them tick? What do they want from you? What are the changes you will see in the professions in the coming years? These are just some of the things you will learn during this compelling and important webinar presented by 30 year pharma industry executive, Spencer Falk, MBA and 35 year Physician Assistant and industry executive David Mittman.
» Register Free!	Sponsored by: Clinician 1 & PANPharma

ON DEMAND Supply Chain Strategy: Managing risk and opportunity in a changing global landscape The supply chain represents a significant amount of the cost base of most bio-pharmaceutical companies and is the critical link between the laboratory and the marketplace. Over the years, improvements made in supply chain operations have focused largely on ways to reduce cost and gain efficiencies in scale. Yet, powerful regulatory and market forces have created new incentives for pharmaceutical companies to fundamentally rethink the way they will manufacture and distribute products in the future, and to re-imagine the role of the supply chain in driving strategic growth, brand differentiation and economic value in the health continuum. In this Webcast, a panel of experts will discuss significant changes the pharmaceutical supply chain is expected to undergo in the coming years and then explore potential scenarios for how pharmaceutical companies might restructure their supply chain strategy and operating models, depending on their unique product portfolio and channel strategy. The discussion will focus on the risks, opportunities and challenges in each of the four future supply chain models -- virtual manufacturer, service innovator, a mass market manufacturer or a profit center ? identified by PricewaterhouseCoopers in its groundbreaking report Pharma 2020: Supplying the Future: Which path will you take?
» Register Free!	Sponsored by: PricewaterhouseCoopers LLP

ON DEMAND Critical Path Decisions for the 4 C's in Life Sciences: Buy, Subscribe or Outsource Your "Order to Cash", Contracts, Chargebacks and Compliance Systems In today's highly competitive and complex life sciences industry, effective contract management and regulatory compliance are critical to your success. Pharmaceutical and biotech companies are continually looking for ways to retain more revenue from commercial contracts, minimize overpayments of chargebacks and incentive rebates while maintaining compliance in a high-stakes regulatory environment that imposes stiff penalties for infractions. Jeff White, Director of Financial and Customer Services for Owen Minor HealthCare Logistics, and Jack Payne, Vice President of CDC Software, reveal the industry specific technologies that can streamline your 4 "C" business processes, "Order to Cash", Contracts, Chargebacks and Compliance with expanded functionality, improved usability, and greater automation. To conserve cash and maximize profits, there are several investment options available, in terms of implementing the 4 "C" business processes. Which investment best fits your business model: the purchase of an on-premise application, a monthly subscription to a "in the cloud" application, or the outsourcing of these processes to a life sciences BPO provider? Our experts present a self evaluation checklist to help you make this critical investment decision.
» Register Free!	Sponsored by: CDC Software

ON DEMAND Unfolding the Road Map of Marketplace Influencers - New Approaches to Optimize Local Level Marketing to Payers, Practitioners and Patients Pharmaceutical companies are evolving their marketing strategies to customize messages and tactics around key influencers. Localizing marketing efforts to respond more proactively to marketplace events can provide tremendous competitive advantage. Performing a thorough customer analysis that examines these "influencers" can help you identify differences in treatment patterns, understand how product prescribing and medication purchasing patterns may vary, and provide critical direction in your brand planning with key customer segments. This analysis identifies WHO makes or influences treatment decisions, from regulators and payers to pharmacists, physicians, and patients. By identifying the influencer, assessing the size and extent of influence, and determining the degree to which their behavior and attitudes can or should be modified, you can determine how best to take advantage of market opportunities and manage issues that should be addressed, including potential hurdles the product must overcome to achieve market growth.
» Register Free!	Sponsored by: Wolters Kluwer

ON DEMAND Pharma Fights Back: How to Combat Counterfeit Drugs Online Counterfeit pharmaceuticals are a dangerous and growing epidemic. The World Health Organization (WHO) estimates that 10% of all drug sales are counterfeit. And, when it comes to the Internet, counterfeit drugs and suspicious pharmacies find fertile ground. The online proliferation of fake drugs puts corporate reputations and profits at risk, but more importantly, they endanger the lives of consumers. How is your company combating this illicit, complex and global drug supply chain? Realizing the need to stay ahead of these sophisticated fraudsters, Purdue Pharma took proactive action against the online sale of counterfeit drugs. In this informative webinar, industry-veteran Richard Widup, Senior Director of Corporate Security at Purdue Pharma, will share his proven strategies for successfully shutting down online counterfeiters and securing the integrity of the pharmaceutical supply chain.
» Register Free!	Sponsored by: MarkMonitor

Featured Whitepapers:

Protect Your Scientific Intellectual Property for the Long Term
Can your electronic research IP records withstand a court challenge?

As more pharmaceutical, bio-sciences and R&D-centric firms move to electronic lab environments, your digital scientific research, formulas and clinical findings are your scientific Intellectual Property. Protecting the integrity and legally defending the authenticity and ownership of such electronic data is critical to your organization’s long-term success. But if you are overlooking this protection in your lab management workflows, you risk losing patent ownership, revenue and consequently your business, if you can't prove authenticity and time of creation, hence your ownership, in a court of law.

This new whitepaper from IP Protection Leader, Surety, explores these concepts and requirements, and discusses how you can implement simple, cost-effective controls to achieve legally defensible scientific IP for the life of the research records.

» View Whitepaper

Advertiser: Surety

Featured Video Series:

Pharma Faceoff: Behind the great pharma video debate series
Special media series from Pharmaceutical Executive:
When pharmaceutical decision makers need news and insights about pharma's future and how to respond to it, they turn to Pharmaceutical Executive. From strategy to marketing to the best new ideas about sales, R&D, regulations, finance, meetings and IT, Pharmaceutical Executive covers it all.

» Visit...